News | August 18, 2023
Honeywell, Recipharm to speed development of inhalers
Honeywell Solstice Air is a hydrofluoroolefin (HFO) propellant in clinical development today for pMDIs
Honeywell Solstice Air is a hydrofluoroolefin (HFO) propellant in clinical development today for pMDIs
Teva will leverage Honeywell’s ‘Energy as a Service’ (EaaS) model
The project is part of a three-year-long partnership between Honeywell and Americares to strengthen the health infrastructure in rural Maharashtra, Uttarakhand and Haryana
Aimed at improving patient outcomes and increasing connectivity for more efficient monitoring In hospitals and homes
Strategic partnership will develop a digital transformation roadmap and create opportunities for co-innovation in healthcare technologies
Further demonstrates Honeywell's commitment to greenhouse gas reduction and support of customers' sustainability goals through innovative new products
New inhalers would have near-zero Global Warming Potential propellant
_1_256_384.png)
Combination of hardware and data analytics software improves real-time and remote patient monitoring; digitizes and automates time-consuming and critical tasks for medical personnel, reducing administrative tasks by 35 per cent
The end user can validate the authenticity of the product by scanning the digital code with the help of a smartphone letting the end user know it is safe to use
Sarah currently serves as the Chief Financial Officer and Principal Accounting Officer for Criteo S.A.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)